Información de la publicación

Portal del Investigador > en > Publications > publication-detail

Detalle_Publicacion

Results from the cohort-expansion stage of a phase I trial of tinostamustine monotherapy in advanced Hodgkin Lymphoma (HL), Non-Hodgkin Lymphoma (NHL) and multiple myeloma (MM) (NCT02576496)

Other conference communications or articles related to authors from the University of Cantabria

Tumor cells in light-chain amyloidosis and myeloma show distinct transcriptional rewiring of normal plasma cell development - Article
Contribution of cerebrospinal fluid sCD19 levels to the detection of CNS lymphoma and its impact on disease outcome - Article
Randomized phase 2 study of weekly carfilzomib 70 Mg/m2 and dexamethasone plus/minus cyclophosphamide in relapsed and/or refractory multiple myeloma (RRMM) patients (GEM-KyCyDex) - Article
Hnrnpk overexpression drives nucleolar aberrancies causing ribosomopathies - Conference object
Genetic subtyping using whole exome sequencing across large B cell lymphoma entities in a series of 109 DLBCL and plasmablastic lymphoma cases - Conference object
30-minute infusion of isatuximab in newly diagnosed multiple myeloma (NDMM) patients: results of a phase 1b study - Conference object
BeEAM (bendamustine, etoposide, cytarabine, melphalan) before autologous stem cell transplantation is safe and effective for resistant/relapsed lymphoma patients. - Article
The clinical utility and prognostic value of multiparameter flow cytometry immunophenotyping in light-chain amyloidosis. - Article
Bendamustine, etoposide, cytarabine, melphalan, and autologous stem cell rescue produce a 72% 3-year PFS in resistant lymphoma. - Article
Detailed characterization of multiple myeloma circulating tumor cells shows unique phenotypic, cytogenetic, functional, and circadian distribution profile. - Article
Multiparameter flow cytometry for staging of solitary bone plasmacytoma: new criteria for risk of progression to myeloma. - Article
Development and validation of a comprehensive genomic diagnostic tool for myeloid malignancies - Article
Splenic diffuse red pulp small B-cell lymphoma displays increased expression of cyclin D3 and recurrent CCND3 mutations - Article
Molecular synergy underlies the co-occurrence patterns and phenotype of NPM1-mutant acute myeloid leukemia - Article
Natural history and cell of origin of TC F3- ZN F384 and PTPN11 mutations in monozygotic twins with concordant BCP-ALL - Article
Discovery of a CD10-negative B-progenitor in human fetal life identifies unique ontogeny-related developmental programs - Article
PLCG1 mutations in cutaneous T-cell lymphomas - Article

Congress: The American Society of Hematology Annual Meeting Abstracts: ASH (65ª : 2023 : San Diego)

Publisher: American Society of Hematology

Year of publication: 2023

No. of pages: 3

Publication type: Conference object

DOI: 10.1182/blood-2023-181822

ISSN: 0006-4971,1528-0020

Publication Url: https://doi.org/10.1182/blood-2023-181822

Read publication

Authorship

SUREDA BALARI, ANNA MARIA

GHESQUIERES, HERVE

MORSCHHAUSER, FRANCK

MUTSAERS, PIM

ENRIQUE MARIA OCIO SAN MIGUEL

JANIK, TOMAS

MANAMLEY, NICK

HILGIER, KASIA

ZINZANI, PIER LUIGI

Download reference

Bib Ris

Back

Researchers portal

Portal del personal investigador

Detalle_Publicacion

Results from the cohort-expansion stage of a phase I trial of tinostamustine monotherapy in advanced Hodgkin Lymphoma (HL), Non-Hodgkin Lymphoma (NHL) and multiple myeloma (MM) (NCT02576496)

Authorship

Download reference